According to the developers, iVAX – a modular technology for in vitro conjugate vaccine expression – is portable and could overcome the challenges of ensuring cold-chain supply of conjugate vaccine products...
Enriching cell-free gene expression system extracts with membrane bound vesicles can significantly increase their ability to produce protein-based products, shows study.